Related Experiment Videos
Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia
E Leibovitz1, N Hazanov, R Zimlichman
1Department of Internal Medicine A, Wolfson Medical Center, Holon, Israel.
Insights
Atorvastatin treatment significantly improved small artery elasticity and reduced blood pressure in patients with severe hypercholesterolemia. This study highlights atorvastatin
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Lipid Metabolism
Background:
- Severe hypercholesterolemia poses significant cardiovascular risks.
- Arterial compliance is a key indicator of vascular health.
- The impact of statins on arterial compliance requires further investigation.
Purpose of the Study:
- To evaluate the effect of atorvastatin on arterial compliance in patients with severe hypercholesterolemia.
- To assess changes in lipid profiles and blood pressure following atorvastatin treatment.
Main Methods:
- Seventeen patients with low-density lipoprotein cholesterol > 170 mg/dL and no other risk factors were enrolled.
- Patients received atorvastatin treatment and were monitored over five visits, every four weeks.
- Arterial compliance, lipid profiles, and blood pressure were measured.
Main Results:
- After 20 weeks, atorvastatin significantly improved lipid profiles.
- Small artery elasticity index increased by 21% (P < .01), while large artery elasticity showed no significant change.
- Systolic and diastolic blood pressure decreased significantly by 6 mm Hg and 3 mm Hg, respectively.
Conclusions:
- Atorvastatin effectively improves small artery elasticity in patients with severe hypercholesterolemia.
- Atorvastatin treatment leads to a significant reduction in both systolic and diastolic blood pressure.
- These findings suggest atorvastatin has beneficial effects on vascular function beyond lipid-lowering.
Background:
We studied the effect of atorvastatin on arterial compliance in patients with severe hypercholesterolemia.
Methods:
Seventeen patients with low-density lipoprotein cholesterol levels above 170 mg/dL, were included in the study, none of whomever received hypolipidemic medication or had other risk factors. Patients were followed for five visits, every 4 weeks.
Results:
After 20 weeks of treatment, lipid profile improved significantly. Large artery elasticity index did not change significantly, but small artery elasticity index increased by 21% (4.6+/-0.5 to 5.6+/-0.9, P < .01). Although none of our patients suffered from hypertension, both systolic and diastolic blood pressure (BP) decreased significantly (6 mm Hg and 3 mm Hg, respectively).
Conclusions:
We conclude that atorvastatin improves the elasticity of small arteries and reduces systolic and diastolic BP in patients with severe hypercholesterolemia.